Sponsor Dossier
Specialised Therapeutics Pharma
Sponsor Dossier for Specialised Therapeutics Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: APLIDIN
- Brand: SKYTROFA
- Brand: YONDELIS
- Brand: YORVIPATH
- Brand: ZEPZELCA
- Device (sponsor): Empty self-injector, electronic
About
Specialised Therapeutics Pharma is an Australian Private Company with ABN 77609261430, registered in Victoria. The entity is active and registered for GST.
Portfolio
Specialised Therapeutics Pharma has 5 brands on the ARTG, of which 5 are indexable and 4 carry a Product Information document. 1 brand is PBS-listed, 4 have a PBAC outcome on record, and 5 have an AusPAR on record. Notable brands include APLIDIN, SKYTROFA, YONDELIS, YORVIPATH, ZEPZELCA.
Therapeutic focus
— Oncology: 3 brands — Endocrinology: 2 brands
PBS footprint
1 brand is PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2025-11-01, across 4 brands with a PBAC outcome on record. The latest AusPAR is 2025-07-01, across 5 brands with an AusPAR on record.